Home > Insider Trading > Filing (0000899243-23-003084)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1707502	Solid Biosciences Inc.	SLDB	Biological Products, (No Disgnostic Substances) (2836)	900943402

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1727460	Ilan Ganot	C/O Solid Biosciences Inc. 500 Rutherford Avenue, Third Floor Charlestown MA 02129		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-01-27	388	$0.00	1,519	No	4	M	Indirect	Wife
Common Stock	Disposition	2023-01-27	141	$7.49	1,378	No	4	S	Indirect	Wife
Common Stock	Acquisiton	2023-01-27	3,883	$0.00	85,973	No	4	M	Direct
Common Stock	Disposition	2023-01-27	1,382	$7.49	84,591	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Indirect	Wife
No	4	S	Indirect	Wife
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2023-01-27	388	$0.00	388	$0.00
Common Stock	Restricted Stock Units	Disposition	2023-01-27	3,883	$0.00	3,883	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,165			No	4	M	Indirect
11,650			No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	19,394	Indirect	See Footnote

Footnotes

Restricted stock units convert into common stock on a one-for-one basis.
Includes 1,462 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on November 30, 2022.
This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The shares were sold pursuant to a written instruction under Rule 10b5-1(c)(1).
Includes 490 shares of common stock and 1,462 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on May 31, 2022 and November 30, 2022, respectively.
Represents 81,931 shares held by Mr. Ganot as an individual, and 4,042 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship.
Represents 19,394 shares held by Adam Ganot and Annie Ganot, and their successors, as the trustees for the Ilan Ganot 2017 Irrevocable Trust dated March 3, 2017.
On January 27, 2022 (the "Grant Date"), Ms. Ganot was granted 1,553 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.
On the Grant Date, the reporting person was granted 15,533 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.